Swiss scientists discover ‘antiviral’ powers of sugar
Swiss and British researchers have modified sugar molecules so that they are capable, by simple contact, of destroying viruses, without toxicity to humans. The method could apply, for example, to the new coronavirus in China.
So-called “virucidal” substances, such as bleach, destroy viruses by simple contact, but they cannot be applied to the human body without causing serious damage, noted the University of Geneva (UNIGE) in a statement.
Most of today’s antiviral drugs work by inhibiting the growth of viruses but are incapable of destroying them. Complicating matters, they are not always reliable: viruses can mutate and become resistant to such treatments.
“To get around these two obstacles and be able to effectively fight against viral infections, we found an entirely different angle of attack”, stresses Caroline Tapparel Vu, a professor in the department of microbiology and molecular medicine of UNIGE who led the research effort along with Francesco Stellacci, a professor at the faculty of engineering sciences and techniques of the Federal Polytechnic School of Lausanne (EPFL).
Nontoxic
Researchers had previously produced a gold-based antiviral. Applying the same concept, they have this time succeeded in developing an antiviral using natural glucose derivatives, called cyclodextrins, according to an article published in the journal Science Advances.
“The advantages of cyclodextrins are numerous: even more biocompatible than gold, and easier to use. They do not trigger a resistance mechanism and are not toxic,” said Samuel Jones, a researcher at the University of Manchester who was cited in the UNIGE press release.
“In addition, cyclodextrins are already widely used, particularly in the food industry, which would facilitate the marketing of pharmaceutical treatments using them,” notes Valeria Cagno of UNIGE.
By simple contact
The modified sugar molecules attract viruses before irreversibly inactivating them. By disrupting the outer layer of the virus, they manage to destroy infectious particles by simple contact, instead of only blocking viral growth.
And this mechanism seems to work regardless of the virus concerned. Scientists have been able to demonstrate this on viruses responsible for respiratory and herpes infections.
A patent has been filed and a spin-off created to study the pharmaceutical development that could be made with this discovery. The cyclodextrins could be administered as a cream, gel or nasal spray.
Hope against epidemics
While drugs for specific viruses, such as HIV or hepatitis C, exist, they only have a narrow application. The development of new broad-spectrum antivirals is considered essential, especially to tackle the most devastating viruses or emerging viruses against which there is no treatment.
This work, according to the authors, could then have a global impact. The compound may also be effective against new emerging viruses the novel coronavirus that started in China and spread overseas.
Popular Stories
More
Swiss Abroad
Aussie adoptee gains Swiss citizenship at 54 thanks to old envelope
Swiss skiers nab top spots in iconic Lauberhorn race
This content was published on
Swiss skier Marco Odermatt has won the Lauberhorn downhill ski race in Wengen, Switzerland, for the third time, just ahead of compatriot Franjo von Allmen.
Switzerland’s neighbours are ‘not role models’ in fiscal policy, says finance minister
This content was published on
Swiss finance minister Karin Keller-Sutter defended the country's compliance with the debt brake at a meeting of her party, the Radical-Liberals, on Saturday.
Pope Francis praises Swiss Guards’ patience with pilgrims
This content was published on
During a private audience on Saturday, Pope Francis praised the Swiss Guards for their "great patience" with pilgrims who visit the Vatican.
Swiss designer Kevin Germanier to design outfits for Eurovision presenters
This content was published on
Designer Kevin Germanier will dress the team of presenters at the 2025 Eurovision Song Contest, which takes place in May in Basel.
Swiss President Karin Keller-Sutter makes official visit to Austria
This content was published on
Karin Keller-Sutter, who took over the rotating Swiss presidency this year, has made her first official visit abroad as president to Austria.
This content was published on
The boss of Swiss Post, Roberto Cirillo, is stepping down at the end of March after six years in the job, the company announced on Friday.
This content was published on
The name and logo of the former Credit Suisse headquarters at Paradeplatz 8 in Zurich's financial centre were officially replaced by those of UBS on Friday.
Outgoing Swiss federal police chief warns of insufficient resources
This content was published on
The outgoing director of the Federal Office of Police (Fedpol), Nicoletta della Valle, has warned that officers, prosecutors and investigators in Switzerland have insufficient resources to do their work.
Swiss university inaugurates Europe’s most powerful centrifuge
This content was published on
The federal technology institute ETH Zurich has inaugurated Europe's most powerful geotechnical centrifuge. Researchers use the instrument to simulate the effects of natural hazards.
Swiss film industry reports successful year in 2024
This content was published on
Swiss films did well in cinemas in 2024, recording over 907,000 admissions, the Federal Statistical Office (FSO) reports. They accounted for almost 9% of all films shown last year in Switzerland.
This content was published on
The University Hospitals of Geneva have developed a test to detect a new strain of the coronavirus which is spreading across the world from China.
Coronavirus expected to hit Swiss tourism industry
This content was published on
Officials say the coronavirus outbreak could lead to a 30-50% drop in the number of Chinese tourists to the Alpine country in the coming weeks.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.